Quanterix
QTRX
NASDAQ
IPO2017
about QTRX
Quanterix develops advanced molecular diagnostic solutions for life sciences research and clinical applications, focusing on the development of innovative Single Molecule Arrays (SMAs) to quantify proteins associated with diseases like cancer and inflammatory conditions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $6.27 | $6.47 | $6.16 | $305.96M | 369.73K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.73 | n/a | 7.15 | -92.77% | -83.31% | 0% |